INFANRIX

Description

INFANRIX (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) is a noninfectious, sterile vaccine for intramuscular administration. Infanrix is indicated for active immunization against diphtheria, tetanus, and pertussis as a 5-dose series in infants and children 6 weeks to 7 years of age.

Immunization Guideline

Primary immunization:

  • 3 doses of 0.5 ml each is administered at 2, 4, and 6 months of age (at intervals of 4 to 8 weeks). The first dose may be given as early as 6 weeks of age

Booster doses:

  • First booster doses is administered at 15 to 20 months of age
  • Second booster dose is given at 4 to 6 years of age

The preferred administration site is the anterolateral aspect of the thigh for most infants younger than 12 months of age and the deltoid muscle of the upper arm for most children 12 months of age to 7 years of age.

Additional information

manufacturer

GlaxoSmithKline

country-of-manufacture

Belgium

vaccine-type

Diphtheria-Tetanus-Pertussis (acellular)

pharmaceutical-form

Liquid, Ready to Use

package-size

1 Dose

route-of-administration

Intramuscular

preservative

None

Contraindications

Severe allergic reaction (e.g., anaphylaxis) after a previous dose of any diphtheria toxoid, tetanus toxoid, or pertussis-containing vaccine, or to any component of INFANRIX. Encephalopathy within 7 days of administration of a previous pertussis-containing vaccine. Progressive neurologic disorders.

Get FREE personalised Vaccination Chart and SMS reminders

Start Now